143 related articles for article (PubMed ID: 34909758)
21. Endothelial Dysfunction as a Primary Consequence of SARS-CoV-2 Infection.
Mezoh G; Crowther NJ
Adv Exp Med Biol; 2021; 1321():33-43. PubMed ID: 33656711
[TBL] [Abstract][Full Text] [Related]
22. DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
Valencia I; Peiró C; Lorenzo Ó; Sánchez-Ferrer CF; Eckel J; Romacho T
Front Pharmacol; 2020; 11():1161. PubMed ID: 32848769
[TBL] [Abstract][Full Text] [Related]
23. Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients.
Montiel V; Lobysheva I; Gérard L; Vermeersch M; Perez-Morga D; Castelein T; Mesland JB; Hantson P; Collienne C; Gruson D; van Dievoet MA; Persu A; Beauloye C; Dechamps M; Belkhir L; Robert A; Derive M; Laterre PF; Danser AHJ; Wittebole X; Balligand JL
EBioMedicine; 2022 Mar; 77():103893. PubMed ID: 35219085
[TBL] [Abstract][Full Text] [Related]
24. Renin-Angiotensin System: An Important Player in the Pathogenesis of Acute Respiratory Distress Syndrome.
Hrenak J; Simko F
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126657
[TBL] [Abstract][Full Text] [Related]
25. ZMPSTE24 Regulates SARS-CoV-2 Spike Protein-enhanced Expression of Endothelial PAI-1.
Han M; Pandey D
Am J Respir Cell Mol Biol; 2021 Sep; 65(3):300-308. PubMed ID: 34003736
[TBL] [Abstract][Full Text] [Related]
26. Endothelial glycocalyx shields the interaction of SARS-CoV-2 spike protein with ACE2 receptors.
Targosz-Korecka M; Kubisiak A; Kloska D; Kopacz A; Grochot-Przeczek A; Szymonski M
Sci Rep; 2021 Jun; 11(1):12157. PubMed ID: 34108510
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical and Transcriptional Analysis of SARS-CoV-2 Entry Factors and Renin-Angiotensin-Aldosterone System Components in Lethal COVID-19.
Haslbauer JD; Stalder A; Zinner C; Bassetti S; Mertz KD; Went P; Matter M; Tzankov A
Pathobiology; 2022; 89(3):166-177. PubMed ID: 34915500
[TBL] [Abstract][Full Text] [Related]
28. Vigilance on New-Onset Atherosclerosis Following SARS-CoV-2 Infection.
Liu Y; Zhang HG
Front Med (Lausanne); 2020; 7():629413. PubMed ID: 33553222
[TBL] [Abstract][Full Text] [Related]
29. Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists.
Steckelings UM; Sumners C
Clin Sci (Lond); 2020 Nov; 134(22):2987-3006. PubMed ID: 33210709
[TBL] [Abstract][Full Text] [Related]
30. Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19-Mechanisms and Therapeutic Targets.
Fodor A; Tiperciuc B; Login C; Orasan OH; Lazar AL; Buchman C; Hanghicel P; Sitar-Taut A; Suharoschi R; Vulturar R; Cozma A
Oxid Med Cell Longev; 2021; 2021():8671713. PubMed ID: 34457119
[TBL] [Abstract][Full Text] [Related]
31. Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19.
Maruhashi T; Higashi Y
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066226
[TBL] [Abstract][Full Text] [Related]
32. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies.
Albini A; Di Guardo G; Noonan DM; Lombardo M
Intern Emerg Med; 2020 Aug; 15(5):759-766. PubMed ID: 32430651
[TBL] [Abstract][Full Text] [Related]
33. Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: A closer look at angiotensin-converting enzyme 2 (ACE2).
Zemlin AE; Wiese OJ
Ann Clin Biochem; 2020 Sep; 57(5):339-350. PubMed ID: 32369402
[TBL] [Abstract][Full Text] [Related]
34. Thromboplasminflammation in COVID-19 Coagulopathy: Three Viewpoints for Diagnostic and Therapeutic Strategies.
Gando S; Wada T
Front Immunol; 2021; 12():649122. PubMed ID: 34177896
[TBL] [Abstract][Full Text] [Related]
35. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19.
Kumar R; Rathi H; Haq A; Wimalawansa SJ; Sharma A
Virus Res; 2021 Jan; 292():198235. PubMed ID: 33232783
[TBL] [Abstract][Full Text] [Related]
36. Vasculopathy in COVID-19.
Flaumenhaft R; Enjyoji K; Schmaier AA
Blood; 2022 Jul; 140(3):222-235. PubMed ID: 34986238
[TBL] [Abstract][Full Text] [Related]
37. Vascular Endothelial Glycocalyx Damage and Potential Targeted Therapy in COVID-19.
Zha D; Fu M; Qian Y
Cells; 2022 Jun; 11(12):. PubMed ID: 35741101
[TBL] [Abstract][Full Text] [Related]
38. The Science Underlying COVID-19: Implications for the Cardiovascular System.
Liu PP; Blet A; Smyth D; Li H
Circulation; 2020 Jul; 142(1):68-78. PubMed ID: 32293910
[TBL] [Abstract][Full Text] [Related]
39. COVID-19 - Endothelial Axis and Coronary Artery Bypass Graft Patency: a Target for Therapeutic Intervention?
Topal G; Loesch A; Dashwood MR
Braz J Cardiovasc Surg; 2020 Oct; 35(5):757-763. PubMed ID: 33118741
[TBL] [Abstract][Full Text] [Related]
40. ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.
Sharma RK; Stevens BR; Obukhov AG; Grant MB; Oudit GY; Li Q; Richards EM; Pepine CJ; Raizada MK
Hypertension; 2020 Sep; 76(3):651-661. PubMed ID: 32783758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
